# Addition of Aspirin to Standard of Care in Oral Cancer

> **NCT05865548** · PHASE2,PHASE3 · COMPLETED · sponsor: **Banaras Hindu University** · enrollment: 60 (actual)

## Conditions studied

- Oral Cancer

## Interventions

- **DRUG:** Aspirin 150 mg
- **PROCEDURE:** Standard of care

## Key facts

- **NCT ID:** NCT05865548
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-17
- **Primary completion:** 2024-08-10
- **Final completion:** 2024-08-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05865548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05865548, "Addition of Aspirin to Standard of Care in Oral Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05865548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*